Journal of Atherosclerosis and Thrombosis
Online ISSN : 1880-3873
Print ISSN : 1340-3478
ISSN-L : 1340-3478

This article has now been updated. Please use the final version.

Diagnosis and Management of Sitosterolemia 2021
Hayato TadaAkihiro NomuraMasatsune OguraKatsunori IkewakiYasushi IshigakiKyoko InagakiKazuhisa TsukamotoKazushige DobashiKimitoshi NakamuraMika HoriKota MatsukiShizuya YamashitaShinji YokoyamaMasa-aki KawashiriMariko Harada-Shibaon behalf of the Committee on Primary Dyslipidemia under the Research Program on Rare and Intractable Desease of the Ministry of Health, Labour and Welfare of Japan
Author information
JOURNAL OPEN ACCESS Advance online publication

Article ID: RV17052

Details
Abstract

Sitosterolemia is an inherited metabolic disorder characterized by increased levels of plant sterols, such as sitosterol. This disease is caused by loss-of-function genetic mutations in ATP-binding cassette (ABC) subfamily G member 5 or member 8 (ABCG5 or ABCG8, respectively), both of which play important roles in selective excretion of plant sterols from the liver and intestine, leading to failure to prevent absorption of food plant sterols. This disorder has been considered to be extremely rare. However, accumulated clinical data as well as genetics suggest the possibility of a much higher prevalence. Its clinical manifestations resemble those observed in patients with familial hypercholesterolemia (FH), including tendon xanthomas, hyper LDL-cholesterolemia, and premature coronary atherosclerosis. We provide an overview of this recessive genetic disease, diagnostic as well as therapeutic tips, and the latest diagnostic criteria in Japan.

Content from these authors

この記事はクリエイティブ・コモンズ [表示 - 非営利 - 継承 4.0 国際]ライセンスの下に提供されています。
https://creativecommons.org/licenses/by-nc-sa/4.0/deed.ja
feedback
Top